JP2020532288A5 - - Google Patents

Download PDF

Info

Publication number
JP2020532288A5
JP2020532288A5 JP2020501311A JP2020501311A JP2020532288A5 JP 2020532288 A5 JP2020532288 A5 JP 2020532288A5 JP 2020501311 A JP2020501311 A JP 2020501311A JP 2020501311 A JP2020501311 A JP 2020501311A JP 2020532288 A5 JP2020532288 A5 JP 2020532288A5
Authority
JP
Japan
Prior art keywords
collection
expression vectors
nucleic acids
acids according
entire
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020501311A
Other languages
English (en)
Japanese (ja)
Other versions
JP7274223B2 (ja
JP2020532288A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2018/069032 external-priority patent/WO2019012082A1/en
Publication of JP2020532288A publication Critical patent/JP2020532288A/ja
Publication of JP2020532288A5 publication Critical patent/JP2020532288A5/ja
Application granted granted Critical
Publication of JP7274223B2 publication Critical patent/JP7274223B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020501311A 2017-07-12 2018-07-12 マイクロサテライト不安定性(msi)癌の予防及び治療のための共通腫瘍ネオアンチゲンをベースとした万能ワクチン Active JP7274223B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17181026 2017-07-12
EP17181026.0 2017-07-12
PCT/EP2018/069032 WO2019012082A1 (en) 2017-07-12 2018-07-12 UNIVERSAL VACCINE BASED ON SHARED TUMOR NEO-ANTIGENS FOR THE PREVENTION AND TREATMENT OF MICRO-SATELLITE INSTABILITY CANCER (MSI)

Publications (3)

Publication Number Publication Date
JP2020532288A JP2020532288A (ja) 2020-11-12
JP2020532288A5 true JP2020532288A5 (enExample) 2021-08-05
JP7274223B2 JP7274223B2 (ja) 2023-05-16

Family

ID=59366234

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020501311A Active JP7274223B2 (ja) 2017-07-12 2018-07-12 マイクロサテライト不安定性(msi)癌の予防及び治療のための共通腫瘍ネオアンチゲンをベースとした万能ワクチン

Country Status (19)

Country Link
US (1) US11578109B2 (enExample)
EP (1) EP3652606B1 (enExample)
JP (1) JP7274223B2 (enExample)
KR (1) KR102709778B1 (enExample)
CN (1) CN111328420B (enExample)
AU (1) AU2018298849B2 (enExample)
BR (1) BR112020000590A2 (enExample)
CA (1) CA3069047A1 (enExample)
DK (1) DK3652606T5 (enExample)
ES (1) ES2940087T3 (enExample)
FI (1) FI3652606T3 (enExample)
HU (1) HUE061840T2 (enExample)
IL (1) IL271966B2 (enExample)
MX (1) MX2020000413A (enExample)
NZ (1) NZ759940A (enExample)
PL (1) PL3652606T3 (enExample)
PT (1) PT3652606T (enExample)
SG (1) SG11202000250PA (enExample)
WO (1) WO2019012082A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3827265A1 (en) 2018-07-26 2021-06-02 Frame Pharmaceuticals B.V. Cancer vaccines for kidney cancer
IL321691A (en) 2018-07-26 2025-08-01 Curevac Netherlands B V arid1a, cdkn2a, kmt2b, kmt2d, tp53 and pten vaccines against cancer
IL280113B2 (en) 2018-07-26 2025-11-01 Curevac Netherlands B V Cancer vaccines for uterine cancer
IL280112B2 (en) 2018-07-26 2025-11-01 Curevac Netherlands B V Cancer vaccines for breast cancer
CA3106562A1 (en) 2018-07-26 2020-01-30 Frame Pharmaceuticals B.V. Off-the-shelf cancer vaccines
CA3106573A1 (en) 2018-07-26 2020-01-30 Frame Pharmaceuticals B.V. Cancer vaccines for colorectal cancer
TWI852977B (zh) * 2019-01-10 2024-08-21 美商健生生物科技公司 前列腺新抗原及其用途
WO2020163802A1 (en) * 2019-02-07 2020-08-13 Arizona Board Of Regents On Behalf Of Arizona State University Cancer specific frameshift vaccines
CN114980920A (zh) 2019-11-18 2022-08-30 詹森生物科技公司 基于突变体calr和jak2的疫苗及其用途
WO2021228999A1 (en) * 2020-05-12 2021-11-18 Institut Curie Neoantigenic epitopes associated with sf3b1 mutations
WO2022009052A2 (en) 2020-07-06 2022-01-13 Janssen Biotech, Inc. Prostate neoantigens and their uses
US20240218019A1 (en) * 2021-04-06 2024-07-04 Board Of Regents, The University Of Texas System Methods and compositions comprising mhc class i peptides

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922315A (en) 1997-01-24 1999-07-13 Genetic Therapy, Inc. Adenoviruses having altered hexon proteins
US8053552B2 (en) * 2002-04-18 2011-11-08 Mtm Laboratories, Ag Neopeptides and methods useful for detection and treatment of cancer
WO2004092338A2 (en) * 2003-04-11 2004-10-28 Diadexus, Inc. Compositions, splice variants and methods relating to cancer specific genes and proteins
CN1824325A (zh) * 2005-12-16 2006-08-30 武汉大学 人乳头病毒dna嵌合疫苗及制备方法和应用
BRPI0717651A2 (pt) * 2006-10-17 2013-12-24 Oncotherapy Science Inc Vacinas de peptídeo para cânceres que expressam polipeptídeos mphosph1 ou depdc1
TW201102081A (en) * 2009-05-11 2011-01-16 Oncotherapy Science Inc TTK peptides and vaccines including the same
US8685896B2 (en) 2009-05-29 2014-04-01 Morphosys Ag Collection and methods for its use
SG183945A1 (en) * 2010-04-09 2012-10-30 Oncotherapy Science Inc Cdca5 peptides and vaccines including the same
ES2575980T3 (es) * 2011-03-24 2016-07-04 Institut National De La Santé Et De La Recherche Médicale (Inserm) Mutante de HSP110 dominante negativo y su uso en el pronóstico y el tratamiento de cánceres
DK2742133T3 (en) * 2011-08-12 2017-12-04 Oncotherapy Science Inc MPHOSPH1 PEPTIDES AND VACCINES CONTAINING THESE
JP5890769B2 (ja) * 2012-12-13 2016-03-22 ループレヒト−カルルス・ウニヴェルジテート・ハイデルベルクRuprecht−Karls−Universitaet Heidelberg がんの予防及び治療のためのmsi特異的なフレームシフトペプチド(fsp)
US9205140B2 (en) * 2012-12-13 2015-12-08 Ruprecht-Karls-Universität MSI-specific frameshift peptides (FSP) for prevention and treatment of cancer
KR101810840B1 (ko) * 2012-12-13 2017-12-20 루프레히트-칼스-유니페어지테트 하이델베르크 암의 예방 및 치료용 msi-특이적 프레임쉬프트 펩티드(fsp)
US20140235456A1 (en) * 2012-12-17 2014-08-21 Virginia Tech Intellectual Properties, Inc. Methods and Compositions for Identifying Global Microsatellite Instability and for Characterizing Informative Microsatellite Loci
US11098367B2 (en) * 2014-01-27 2021-08-24 Yale University Methods of identifying patients responsive to immunotherapeutic strategies
PE20180670A1 (es) * 2015-05-20 2018-04-19 Broad Inst Inc Neoantigenos compartidos
CN106350578A (zh) * 2015-07-13 2017-01-25 中国人民解放军第二军医大学 Ny-eso-1在微卫星不稳定性肠癌的诊断和治疗中的应用
US12150980B2 (en) 2015-07-30 2024-11-26 Modernatx, Inc. Concatemeric peptide epitope RNAs

Similar Documents

Publication Publication Date Title
JP2020532288A5 (enExample)
JP2018100276A5 (enExample)
JP2017140920A5 (enExample)
JP2020054657A5 (enExample)
JP2019533243A5 (enExample)
JP2019520713A5 (enExample)
JP2017157543A5 (enExample)
JP2022077837A5 (enExample)
RU2018108575A (ru) Применение гвоздя в качестве заклёпки
TH178709S (th) ของเล่น
TH178708S (th) ของเล่น
TH69689S1 (th) ของเล่น
TH69691S1 (th) ของเล่น
TH71956S1 (th) ของเล่น
TH178712S (th) ของเล่น
TH71957S1 (th) ของเล่น
TH69685S1 (th) ของเล่น
TH178710S (th) ของเล่น
TH178707S (th) ของเล่น
TH69688S1 (th) ของเล่น
TH183550S (th) ของเล่น
TH183551S (th) ของเล่น
TH71254S1 (th) หลอดดูด
TH69690S1 (th) ของเล่น
TH178711S (th) ของเล่น